Summary. Relatively undisturbed samples of human oviduct fluid were obtained by aspiration into a Silastic catheter inserted through the fimbriated end of the oviduct during surgical laparotomy. The concentrations of Na, Cl, K, Ca, Mg, S and P were determined in picolitre aliquots of this fluid using X-ray spectrometry by electron probe excitation. Human 
Introduction
The oviduct provides the mUieu for several critically important reproductive events, including transport of ova and spermatozoa, conditioning of the gametes, fertilization, and preimplant¬ ation embryonic development. Extensive work on the composition of oviduct fluid in a number of species has involved the use of double-ligature or cannulation techniques, and collection of fluid for long periods (for review, see Johnson & Foley, 1974) . Up to the present, only two chemical analyses of human tubai fluid have been reported (Lippes, Enders, Pragay & Bartholomew, 1972; David, Serr & Czernobilsky, 1973) . Both studies indicated that human oviduct fluid contains higher concentrations of chloride and potassium than does human serum. Roblero, Biggers & Lechene (1976) and Borland, Hazra, Biggers & Lechene (1977) Sample preparation and electron probe microanalysis were by the techniques described by Lechene (1974) , Lechene & Warner (1977) and Borland et al. (1977) . The samples were first diluted 1:1 or 1:2 with distilled water. The samples and a series of standard solutions were placed on the surface of a beryllium support covered with mineral oil with calibrated volumetric pipettes (35-80 pi). The oü on the beryllium block was removed with an m-xylene wash and the sample on the block was freeze-dried under vacuum. The analyses were performed on an auto¬ mated Cameca MS/46 microprobe. X-ray emissions from Na and Mg were analysed using potassium acid phthalate diffracting crystals; P, Cl, and Ca required the use of pentaerythritol diffracting crystals. The concentrations of the elements in the unknown samples were deter¬ mined with respect to the counts obtained from identical volumes of 5 standard solutions each of which contained known amounts of the 7 elements being studied. The electron probe measures the total content of all 7 elements in each sample and therefore the concentrations of Ca and Mg included the bound and unbound forms of these elements, and those of S and represented the organic and inorganic forms. The electron probe has been shown to analyse reliably elements in fluid volumes as smaU as 10 pi provided the elemental concentrations are greater than 0-3 mM (Lechene & Warner, 1977 Table 1 .
Results and Discussion
The mean concentrations of Na, Cl, K, Ca, Mg, S and in human tubai fluids from seven patients are shown in Table 2 . The ionic composition of the fluid was characterized by high con¬ centrations of and Cl, but low concentrations of Ca, relative to corresponding serum levels. The mean concentrations of the 7 elements in the oviduct fluids of our study are compared to previous elemental analyses of human tubai fluid (Table 3) . Lippes et al. (1972) and David et al. (1973) also reported that and Cl concentrations in oviduct fluid are consistently higher than in serum. The former investigators also noted that Ca concentrations in oviduct fluid are at the lower end of the normal range of the corresponding serum levels. The results of our own study show similar trends, but also indicate much higher concentrations of in human oviduct fluid than previously reported. Human tubai fluid contains 4-5-fold higher concentrations of than does human serum. The Ca concentration in oviduct fluid is less than half the serum Ca levels (Table 3) , perhaps reflecting lower concentrations of protein in tubai fluid than in serum (David et al, 1973) which could maintain Ca in a protein-bound form. The Mg concentration was not (Roblero et al, 1976; Borland et al, 1977) . The (Steptoe & Edwards, 1976 , 1978 . Further studies are needed to determine the importance of the ionic composition of the oviduct fluid for normal human preimplantation development.
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